Since successful antiretroviral therapies have made HIV a treatable condition, more HIV patients who are also infected with hepatitis B or C are experiencing the progression of their liver disease. In the face of this novel challenge, experts in the field convened to share information and opinions on the management of such patients.
On April 23, the AIUM?s third annual Ultrasound Practice Forum, entitled “Patient Safety and Quality: The Role of Ultrasound” took place in Baltimore, Maryland. Fifty-six individuals representing 30 organizations joined in discussions on training and exam guidelines, scope of practice, and the potential impact of reimbursement on accreditation in ultrasound.
The U.S. Department of Health and Human Services (HHS) has launched the Pandemic Flu Leadership Blog, a five-week-long blog about pandemic preparedness. Participant bloggers include some of the nation?s most influential business, health care, faith-based and community leaders.
World-renowned scientists will convene at George Mason University on May 21 and 22 to call for a 10-year intellectual revolution ? the “decade of the mind.”
Stroke prevalence varies widely from state to state, with some states and U.S. territories having more than double the stroke prevalence of others, according to a new report from the Centers for Disease Control and Prevention (CDC).
The main responsibility for carrying out the United Nations Global Counter-Terrorism Strategy ?falls squarely on Member States,? a senior UN official today told a symposium in Vienna convened to translate the landmark plan from words into action.
Elsevier announced today the inaugural issue of a new journal, Molecular Oncology ? a journal for discovery-driven translational cancer research, published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS).
Fear of stigma and discrimination remains one of the biggest factors in preventing people from seeking treatment for mental illnesses.
Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Employees who participated in a worksite health program improved blood pressure control by 9 percent and diabetes control by 15 percent, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.